Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a ...

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside ...

Small-cap REITs have taken a beating this year; shares in my sample set of 91 REITs (under $4 billion in market cap) have fallen an average of -7.1% year-to-date. As you can see below, there are two ...

Iovance Biotherapeutics and Intellia Therapeutics are two innovative small-cap biotechs. Both companies face serious issues despite Wall Street's high price targets for them. Any of the "Magnificent ...

Small caps, as an asset class, are typically associated with US based companies garnering a majority of sales from the US vs. abroad. This compares to their large cap brethren which are typically more ...

Pulmonary sarcoidosis patients could soon get the treatment option they've been waiting for from aTyr Pharma. MoonLake Immunotherapeutics is running multiple phase 3 programs for its lead candidate.